Search
for
Sort by
Research 601–630 of 1000+
- Ritlecitinib in severe alopecia areata: a profile of its use
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Medications
- MicroRNA in skin diseases
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- New Treatments for Hair Loss
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Epigenetic regulation in adult stem cells and cancers
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- 861 Frontal fibrosing alopecia (FFA) under dynamic optical coherence tomography (D-OCT)
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- 864 Catalytic-dependent and -independent activities of Polycomb repressive complex 1 differentially regulate skin stem cell specification
- 860 Understanding cellular & molecular responses in the treatment of pediatric lymphatic anomalies
- Modern Management Approaches for Alopecia Areata
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- New therapies for alopecia areata
- Latest Advances in Inflammatory Skin Disease